Q1 2024 13F Holders as of 31 Mar 2024
-
Type / Class
-
Equity / GENOMIC REV ETF
-
Total 13F shares
-
21,051,021
-
Share change
-
+608,250
-
Total reported value
-
$605,315,066
-
Put/Call ratio
-
191%
-
Price per share
-
$28.76
-
Number of holders
-
278
-
Value change
-
+$15,377,386
-
Number of buys
-
84
-
Number of sells
-
137
Institutional Holders of ARK ETF TR - GENOMIC REV ETF (ARKG) as of Q1 2024
As of 31 Mar 2024,
ARK ETF TR - GENOMIC REV ETF (ARKG) was held by
278 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
21,051,021 shares.
The largest 10 holders included
Main Management ETF Advisors, LLC, BNP PARIBAS FINANCIAL MARKETS, MORGAN STANLEY, WELLS FARGO & COMPANY/MN, UBS Group AG, JPMORGAN CHASE & CO, LPL Financial LLC, CITIGROUP INC, BANK OF AMERICA CORP /DE/, and STATE OF WISCONSIN INVESTMENT BOARD.
This page lists
279
institutional shareholders reporting positions in this security
for the Q1 2024 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.